Session I: Fuch's Corner: Where are we now, and where are we going | ASCRS
April 25, 2025 | Los Angeles, CA

2025 ASCRS SUBSPECIALTY DAY

This content is only available to 2025 ASCRS Subspecialty Day physician registrants

To log in, click the teal "Login" button in the upper right-hand corner of this page. If you are logged in but still do not have access, please check your 2025 Annual Meeting registration.

Session I: Fuch's Corner: Where are we now, and where are we going

About this Session

Session Moderators: Franklin Price, MD; Winston D Chamberlain, MD, PhD, ABO

Fuch's Corner session is designed to provide updates in diagnosis and best practices and techniques. Expert faculty will discuss innovations in treatments of endothelial disease. New this year, Session I will feature an invited lecture on the evolution of injectable endothelial cell technology.


Presentations in this Session

  • DMEK Is the Current Gold Standard to Judge Other Treatments By
    Marianne O. Price, PhD
  • DMEK Vs DSEK- Prospective Comparisons
    Jennifer R. Rose-Nussbaumer, MD
  • Dso Current Status and Results
    Gregory Moloney, FRANZCO, FRCSC
  • Injection of Cultured Endothelial Cells- Current Studies
    David D. Verdier, MD
  • Allogenic Cell Therapy
    Zaina Al-Mohtaseb, MD, ABO
  • Molecular Targets for Treating Fuchs
    Mark A. Greiner, MD
  • Genetics of Fuchs and Potential Treatments
    Keith H Baratz, MD